Trial Condition(s):
Contraception
JAYDESS Drug Utilization Study in Sweden
Bayer Identifier:
16903
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
- To describe characteristics (demographic, clinical, social) of first time users of Jaydess
- To estimate the duration of use of Jaydess
- To study switching patterns, e.g. what are the hormonal contraceptive methods used before and what are the methods after discontinuing Jaydess
- To study off-label use of Jaydess
Inclusion Criteria
- Swedish women who were dispensed a JAYDESS from a Swedish Pharmacy anytime 2014-2017
Exclusion Criteria
No exclusion criteria
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations | |
|---|---|
Locations Many Locations Many Locations, Sweden | Contact Us: E-mail: [email protected] Phone: (+) 1-888-8422937 |
Trial Design
Pharmacoepidemiological study (Drug Utilization Study) of JAYDESS use in routine clinical practice in Sweden
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- Duration of use of JAYDESSTimeframe: Up to 6 years
- Indication for useTimeframe: At insertion
Secondary Outcome
- Age at insertion and removalTimeframe: Up to 6 years
Additional Information
Copyright © Bayer
Powered by
